Combination therapies for mycosis fungoides/Sézary syndrome: biologic rationale and recommendations
Int J Dermatol
.
2021 Sep;60(9):e362-e364.
doi: 10.1111/ijd.15436.
Epub 2021 Feb 9.
Authors
Daniel J Lewis
1
,
Alain H Rook
1
Affiliation
1
Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
PMID:
33559132
DOI:
10.1111/ijd.15436
No abstract available
Publication types
Letter
MeSH terms
Biological Products*
Humans
Lymphoma, T-Cell, Cutaneous*
Mycosis Fungoides* / drug therapy
Sezary Syndrome* / drug therapy
Skin Neoplasms* / drug therapy
Substances
Biological Products